Financial Performance - SQM's Q2 2025 revenue reached US$1,043 million[7], gross profit was US$254 million[7], and net income totaled US$308 million[7] - Earnings per share stood at US$0.31[7] - Lithium LTM revenue reached $1,977 million[12], with a gross profit of $410 million[12] - Iodine LTM revenue reached US$985 million[23], with a gross profit of US$523 million[23] - Specialty Plant Nutrition LTM revenue reached US$946 million[33], with a gross profit of US$146 million[33] - Potassium LTM revenue reached US$217 million[40], with a gross profit of US$28 million[40] - Industrial Chemicals LTM revenue reached US$74 million[46], with a gross profit of US$28 million[46] Market Dynamics and Outlook - The global lithium market is expected to grow by approximately 17% in 2025[18] - SQM anticipates a sales volume growth of around 10% in the Lithium Chile division compared to 2024[18] - The company expects to sell approximately 20,000 tons of LCE for the International Lithium Division in 2025[18] - Global iodine demand growth is updated to less than 1% in 2025 compared to 2024[29] - SQM expects a market growth rate of around 4-5% in 2025 for Specialty Plant Nutrition[36] - Potassium sales volume for 2025 is expected to decline by 50% compared to 2024[42] Strategic Investments - Total Capex for 2025 is estimated at US$750 million, including maintenance[21] - Iodine and Nitrates total capex for 2025 is approximately US$350 million, including maintenance[31] Market Share - SQM holds approximately 17% of the global lithium chemical market[12] - SQM holds approximately 37% of the global iodine market[28] - SQM holds approximately 41% of the global KNO3 market[38] - SQM holds less than 1% of the global potash market[43] - SQM holds approximately 32% of the global industrial potassium nitrate market[49]

Financial Performance - GAAP Net Income was $102 million or $027 per share[11] - NAV-Based Total Return was 197% annualized[11] - Net Investment Income was $65 million or $017 per share[11] - Adjusted Net Investment Income was $66 million or $018 per share[11] - Net Asset Value was $2297 million or $612 per share as of June 30 2025[11] Investment Portfolio - The CLO portfolio grew by 27% to $3169 million as of June 30 2025 from $2499 million as of March 31 2025[11, 18] - CLO debt investments totaled $1489 million with 79% in the U S and 21% in Europe[11] - CLO equity investments totaled $1680 million with 92% in the U S and 8% in Europe[11] - The company purchased $906 million of CLO investments and sold $159 million[11] - The weighted average GAAP yield for the quarter based on amortized cost was 156% on the total CLO portfolio[11] Distributions - The company received $159 million in recurring cash distributions from the investment portfolio or $042 per share[11] - The distribution rate was 172% based on the August 18 2025 closing stock price of $559 and a monthly distribution of $008 per common share declared on August 7 2025[11]

Q2 2025 Financial Performance - Lowe's reported positive comparable sales growth of +1.1%[1] and a gross margin of 33.8%[1], which is an increase of +34 basis points compared to the previous year[1] - Adjusted operating margin reached 14.7%[2], up +23 basis points year-over-year[2], with diluted EPS at $4.27[2], a +2.4% increase[2], and adjusted diluted EPS at $4.33[2], a +5.6% increase[2] - The company returned $645 million to shareholders through dividends[2] Sales Trends - Comparable transactions decreased by -1.0%[3], while the comparable average ticket increased by +0.3% to $104.60[3] - Online sales growth experienced a decline of -6.4%[3] - Monthly comparable sales performance varied, with May at -1.8%[3], June at +2.9%[3], and July at +7.5%[3] - Comparable sales by ticket size showed growth in the >$500 range at +3.6%[3], a decrease in the $100-$500 range at -1.4%[3], and a decrease in the <$100 range at -0.1%[3] - Positive comparable sales were achieved in 9 out of 14 product categories[5], including Building Materials, Lawn & Garden, and Appliances[5] Strategic Initiatives - Lowe's closed on the acquisition of Artisan Design Group (ADG)[6] - Pro penetration has increased from approximately 19% in 2019 to approximately 30% in 2025[23] - Lowe's announced the acquisition of Foundation Building Materials (FBM) on August 20, 2025[12] Foundation Building Materials (FBM) Acquisition - FBM has approximately $6.5 billion in pro forma 2024 revenue and $635 million in adjusted EBITDA[27] - The purchase price of $8.8 billion reflects a multiple of 13.4x adjusted EBITDA[50]

Financial Performance - Second quarter revenues reached $84 million with a TCE (Time Charter Equivalent) rate of $72,000 per day[7] - Net income was $17.7 million, and adjusted net income was $24.8 million[7] - Earnings Per Share (EPS) was $0.33, and adjusted EPS was $0.46[7] Guidance and Outlook - The company reconfirmed its 2025 revenue guidance of approximately $340-360 million, with a TCE rate of $72,000-77,000 per day[7] - Adjusted EBITDA for 2025 is reconfirmed at around $250-270 million[7] Balance Sheet and Refinancing - Refinancing of Flex Courageous was completed, yielding net proceeds of approximately $43 million[27, 31] - Three refinancings are expected to generate around $132 million in net proceeds and lower the average pro forma cost of debt to approximately 5.6%[31] - The company's interest rate swap portfolio stood at $850 million (notional) with a weighted average rate of 2.33%[34] Dividends and Share Buy-Back - A dividend of $0.75 per share was declared for the second quarter[7] - The dividend per share for the last twelve months is $3.00[7] - A share buy-back program of up to $15 million has been launched[7, 39] Operational Updates - Two out of four planned drydockings have been completed ahead of schedule[8, 13] - The estimated average cost of all four drydockings is approximately $5.7 million per vessel[13] Market Trends - Global LNG exports YTD-2025 amounted to 244.7 MT, representing a 2% increase[41] - US LNG exports have surged, accompanied by approximately 24% growth in European LNG imports[40, 41]

Financial Performance - Total contract revenues increased by 14.5% from $1.2031 billion in Q2 2025 to $1.3779 billion in Q2 2026[5] - Organic revenue growth was 3.4%[5] - Adjusted EBITDA increased by 29.8% from $158.3 million in Q2 2025 to $205.5 million in Q2 2026[5] - Adjusted EBITDA margin improved by 175 bps from 13.2% in Q2 2025 to 14.9% in Q2 2026[5] - Adjusted diluted EPS increased by 35.4% from $2.46 in Q2 2025 to $3.33 in Q2 2026[5] Backlog and Outlook - Total backlog increased by 16.9% year-over-year[24] - Next 12 months backlog increased by 20.2% year-over-year[24] - The company reaffirms fiscal year 2026 revenue outlook range of $5.290 billion to $5.425 billion, representing a growth of 12.5% to 15.4% over the prior year[31] Debt and Liquidity - Total notional amount of debt was $1.035 billion in Q2 2026[25] - Notional net debt was $1.0065 billion in Q2 2026[25] - Liquidity was $545.9 million in Q2 2026[25]

Market Position and Strategy - Public homebuilders have increased their market share from 27% in 2012 to approximately 53% in 2024[15] - The company focuses on capital efficiency in land acquisition through optioned land, land banking, joint ventures, rolling takedowns, and seller financing[45] - The company is strategically focused on driving shareholder returns through land acquisition, improved operations, and buybacks & dividends[39] Financial Performance - The company's diluted earnings per share (EPS) has grown at a compound annual growth rate (CAGR) of 28%, reaching $1501 in FY 2024[54] - The company has repurchased approximately 52% of its shares since 2016, totaling 91 million shares at an average price of $50, and has paid approximately $644 million in dividends[63] - The company's revenue from home sales increased from $6937357000 in FY 2020 to $10563332000 in FY 2024[66] - The company's return on beginning equity was 231% in FY 2024[66] Industry Trends - The new home premium has compressed from a historical 17% to 3% in 2025, making the value proposition of a new home compelling compared to a used home[23] - The median age of owner-occupied U S homes is over 40 years, compared to 32 years in 2005[27] - Housing starts have not kept pace with household growth, indicating an undersupplied market[20] Land and Operations - The company operates in 24 states and over 60 markets[33] - The company's total addressable market (TAM) consists of approximately 575000 housing transactions with buyers having income greater than $200K[73]

COVID-19 Landscape and Strategy - COVID-19 is the leading cause of hospitalizations and death from respiratory viruses in the U S, with 460,000 hospitalizations and 45,200 deaths between October 1, 2023, and June 15, 2024[7] - The company believes COVID-19 vaccines do not provide sufficient protection, with vaccine effectiveness against hospitalization for immunocompromised adults at a maximum of approximately 36% within 7-59 days of the 2023-2024 vaccine dose[19] - Monoclonal antibodies have demonstrated a significant reduction in the risk of symptomatic COVID-19, with pemivibart showing an 84-94% reduction in risk in ordinary Americans[22] - The company aims to provide Americans with a choice for COVID-19 protection through VYD2311, a monoclonal antibody with high efficacy and long duration of protection, contrasting with the reactogenic and modestly effective COVID-19 vaccines[48, 49] Pipeline and Development - Pemgarda has received emergency use authorization (EUA) from the U S FDA in March 2024 for pre-exposure prophylaxis of COVID-19 in certain immunocompromised persons[29] - VYD2311 is designed to be a high potency, long half-life monoclonal antibody for COVID-19, with an observed IM half-life of 76 days in the first-in-human trial[39, 40] - The company is planning a Phase 2/3 clinical trial for VYD2311 for the prevention of COVID-19, supported by a single, randomized, double-blind, placebo-controlled trial[29] - The company is in the discovery phase for RSV prevention and early discovery for measles and influenza prevention[29] Financials - Q2 2025 Pemgarda net product revenue was $11 8 million[66] - The company ended Q2 2025 with approximately $34 9 million in cash and cash equivalents[66]

Q2 2025 Earnings Call August 20, 2025 G1_Dallas T1 Energy _ Q2 2025 Earnings Call Pictured: Production lines at G1_Dallas T1 Energy _ Q2 2025 Earnings Call Participants and Agenda Prepared Remarks Daniel Barcelo Chairman of the Board and Chief Executive Officer Jaime Gualy Chief Operating Officer Andy Munro Chief Legal & Policy Officer ▪ Corning supply agreement ▪ Policy overview ▪ T1's OBBB compliance road map Evan Calio Chief Financial Officer Q&A Jeff Spittel EVP, Investor Relations and Corporate Develop ...

Q2 2025 Key Highlights - Hotel GMV reached RMB 26911 million[22] - Legacy-Huazhu RevPAR decreased by 38% year-over-year[12,24] - Legacy-DH RevPAR increased by 81% year-over-year[12,26] - Total number of rooms in operation increased by 183% year-over-year, reaching 1184915[12,14,21] - H Rewards members increased by 175% year-over-year, totaling 288 million[12,15,62] - Room nights booked by members increased by 288% year-over-year, exceeding 60 million[12,16] - Manachised and Franchised (M&F) revenue increased by 228% year-over-year, reaching RMB 29 billion[18,75] - Total revenue increased by 45% year-over-year, reaching RMB 64 billion[18,70] - Total Adjusted EBITDA increased by 113% year-over-year, reaching RMB 23 billion[19,70] - Adjusted Diluted EPS increased by 95% year-over-year, reaching RMB 042[19] Financial Performance - Total revenue for Q2 2025 was RMB 6426 million, a 45% increase year-over-year[18,70] - Adjusted EBITDA for Q2 2025 was RMB 2270 million, an 113% increase year-over-year[19,70] - M&F revenue for Q2 2025 was RMB 2865 million, a 228% increase year-over-year[18,75] - M&F Gross Operating Profit for Q2 2025 was RMB 1896 million, a 232% increase year-over-year[18,77] Network and Product Development - Hanting Hotels ranked No1 on the "World's Top 50 Hotel Brands" list with 378569 rooms in operation as of June 30, 2025[30,32,117] - The company is enhancing its presence in lower-tier cities[46] - The company is stepping up the development of the upper-midscale segment, with a 233% year-over-year increase in the number of upper-midscale hotels in operation and pipeline[50,51] Guidance - The company projects M&F revenue to grow 20%-24% in Q3 2025 compared to Q3 2024[101] - The company projects total revenue to grow 2%-6% in Q3 2025 compared to Q3 2024, or 4%-8% excluding DH[103]

Financial Performance - Total net revenue grew by 124% year-over-year to RMB 2,9003 million ($4049 million)[8] - Adjusted EBITDA grew by 112% year-over-year to RMB 1,3718 million ($1915 million) with a margin of 473%[8] - The company obtained RMB 4,451 million ($6213 million) of new debt financing/refinancing facilities[8] - The company raised net proceeds of $676 million in aggregate through CB and equity new issuance[8] Data Center Capacity and Utilization - New customer commitments (net) reached +14,398 sqm[8] - Total area committed increased by 81% year-over-year to 663,959 sqm[8] - Additional area utilized (net) was +16,763 sqm[8] - Total area utilized reached 479,186 sqm, a +141% year-over-year increase, resulting in a utilization rate of 775%[8] - Capacity in service reached 618,060 sqm with a total IT power of 1,326 MW[29] Backlog and Delivery - Backlog at 2Q25 was 184,773 sqm with approximately 35% scheduled for delivery in 2H25, 35% in FY26, and 30% thereafter[16] DayOne Updates - DayOne's net revenue reached $855 million, with an adjusted EBITDA of $297 million and an adjusted EBITDA margin of 347%[64] - DayOne's utilized IT power reached 213 MW[31] FY25 Business Outlook - The company projects revenue between RMB 11,290 million and RMB 11,590 million, implying a year-over-year growth of 94% - 123%[63] - Adjusted EBITDA is expected to be between RMB 5,190 million and RMB 5,390 million, representing a year-over-year increase of 64% - 105%[63] - Updated Capex (After ABS & C-REIT) is expected to be ~RMB 2,700 million, a (103%) decrease[63]